Shibahara, Hidetoshi http://orcid.org/0000-0001-9130-4410
Shiroiwa, Takeru
Ishiguro, Megumi
Nakamura, Masato
Hasegawa, Junichi
Yamaguchi, Shigeki
Masuda, Yuriko
Sakamoto, Junichi
Tomita, Naohiro
Fukuda, Takashi
Funding for this research was provided by:
EA Pharma Co., Ltd.
Taiho Pharmaceutical
Chugai Pharmaceutical
Terumo
Takeda Pharmaceutical Company
Daiichi-Sankyo
Yakult Honsha
Article History
Received: 14 September 2020
Accepted: 29 November 2021
First Online: 24 January 2022
Declarations
:
: I have no conflicts of interest to declare.
: The study was conducted in accordance with the Declaration of Helsinki and the Ethical Guidelines for Clinical Research in Japan, and was approved by the institutional review boards of each participating institute.
: Written informed consent was received from all patients before their enrollment.